ClinicalTrials.Veeva

Menu

Noninvasive Vagal Nerve Stimulation and Cognitive Rehabilitation

Shirley Ryan AbilityLab logo

Shirley Ryan AbilityLab

Status

Enrolling

Conditions

Traumatic Brain Injury

Treatments

Device: Transcutaneous auricular vagus active nerve stimulation
Device: Transcutaneous auricular vagus sham nerve stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT06589362
STU00221084

Details and patient eligibility

About

The purpose of this study is to examine the feasibility and preliminary efficacy of using transcutaneous auricular vagus nerve stimulation (tVNS) to enhance cognitive recovery in patients with mild-moderate traumatic brain injury (TBI).

Full description

Eligible participants will be invited to two sessions, 2-7 days apart. In each session, either active tVNS or sham stimulation will be administered while the participants are performing tasks of executive functions. The order of the sessions (tVNS vs Sham) will be counterbalanced across participants.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

In inpatient rehabilitation due to recent Traumatic Brain Injury, ages 18-65 years.

Ability to independently use a keyboard. Able to understand and communicate in English (according to clinical judgment). Able to independently provide consent to participate. Orientation to place, time, and situation (two consecutive scores of 25 or more on the Orientation Log(O-Log)40. This scale is routinely administered during acute rehabilitation stay.

Exclusion criteria

Acute medical issues requiring close physician or nursing monitoring. Bioelectrical implants, including pacemakers. Pregnancy or persons who are lactating. Significant gross or fine motor weakness. Significant, ongoing communication or comprehension impairments (such as aphasia) that would affect an individual's ability to complete the required assessments.

Acute agitation or behavioral issues, as defined by a last Agitated Behavior Scale Score greater than 21 (routinely administered during acute rehabilitation stay, that would affect an individual's ability to participate in the required assessments.

Severely impaired memory retention (Score lower than 3 in the 3 Word Delayed Recall test, routinely administered during acute rehabilitation stay.

Diagnosis of depression. Active substance abuse.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

60 participants in 2 patient groups

Transcutaneous auricular vagus nerve stimulation
Active Comparator group
Description:
Active vagus nerve stimulation.
Treatment:
Device: Transcutaneous auricular vagus active nerve stimulation
Sham Transcutaneous auricular vagus nerve stimulation
Sham Comparator group
Description:
Sham vagus nerve stimulation.
Treatment:
Device: Transcutaneous auricular vagus sham nerve stimulation

Trial contacts and locations

1

Loading...

Central trial contact

Shira Cohen-Zimerman, PhD; Katy Magee, M.H.S

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems